| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |